Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

52
Delayed Quote. Delayed Nasdaq - 08/21 04:00:00 pm
47.75 USD   -1.73%
1d ago Mylan Launches Generic Xeloda® Tablets
1d agoDJADR Shares End Mixed; Luxottica Shares Active
2d ago MYLAN : Launches Generic Precedex™ Injection - Another Key Product Ap..
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/15/2014 08/18/2014 08/19/2014 08/20/2014 08/21/2014 Date
46.45(c) 46.48(c) 47.04(c) 48.59(c) 47.75(c) Last
6 054 074 3 923 385 4 564 412 7 589 440 3 712 346 Volume
+0.65% +0.06% +1.20% +3.30% -1.73% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells... 
Sector
Pharmaceuticals
Calendar
09/18Shareholder meeting
Surperformance© rating of Mylan Inc
Trading Rating : Investor Rating :
More about the company
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 691 M
EBIT 2014 1 968 M
Net income 2014 1 102 M
Debt 2014 6 349 M
Yield 2014 -
Sales 2015 8 562 M
EBIT 2015 2 350 M
Net income 2015 1 690 M
Debt 2015 4 773 M
Yield 2015 -
PER 2014 19,21
PER 2015 13,68
EV / Sales 2014 3,19x
EV / Sales 2015 2,68x
Capitalization 18 175 M
More Financials
Latest news on MYLAN INC
1d ago Mylan Launches Generic Xeloda® Tablets
1d agoDJADR Shares End Mixed; Luxottica Shares Active
2d ago MYLAN : Launches Generic Precedex™ Injection - Another Key Product Approva..
2d ago MYLAN : Launches Generic Precedex(TM) Injection - Another Key Product Approval
08/11 MYLAN : Launches Generic Xeloda® Tablets
08/08 Delphi to contest pressure to file U.S. taxes despite UK tax base
08/08 MYLAN : Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With ..
08/07DJADR Shares End Lower; Statoil Shares Trade Actively
08/07DJU.S. Stock Slide; Dow Industrials Fall to Lowest Since April
08/07 MYLAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
08/07 MYLAN : Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With ..
08/07 MYLAN : 2Q profit drops 30 percent
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
Mylan Inc : Income Statement Evolution
More Financials
EPS Revisions
Mylan Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF